Immunotherapy News and Research

Latest Immunotherapy News and Research

Death receptor pathway drives resistance to CAR T cell therapy

Some cancer cells refuse to die, even in the face of powerful cellular immunotherapies like CAR T cell therapy, and new research from the Abramson Cancer Center of the University of Pennsylvania is shedding light on why.

30 Jan 2020

New target protein linked to regulation, movement of tumor-associated macrophages

Developing a therapy to combat cancer remains one of the most difficult challenges in medical research. Cancer owes its notorious identity to the fact that the cancer cells use the host's own immune system to grow and spread, ultimately becoming deadly.

30 Jan 2020

Nanoparticle Trojan horse approach to clearing atherosclerotic plaques

Researchers from Michigan State University and Stanford University have designed special nanoparticles which could break down an atherosclerotic plaque from within. This could prevent heart attacks say researchers. The study titled, “Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis,” was published in the latest issue of the journal Nature Nanotechnology.

29 Jan 2020

New therapeutic strategy to fight against advanced melanoma

Scientists from the Centenary Institute have developed a new therapeutic strategy that could potentially help the fight against advanced-stage melanoma.

29 Jan 2020

Groundbreaking study to investigate why cancer returns in some people and not others

An eminent philanthropist and three time cancer survivor Dr James Hull has joined forces with six universities across the country to investigate why cancer returns in some people and not others.

28 Jan 2020

Avacta demonstrates initial proof-of-concept for TMAC drug conjugates in pre-clinical study

Avacta Group plc, the developer of Affimer biotherapeutics and reagents, is pleased to announce that it has demonstrated initial proof-of-concept for its proprietary new class of drug conjugate, TMAC, in a pre-clinical animal model of cancer.

From Avacta Life Sciences Ltd. 28 Jan 2020

The Mark Foundation Center for Advanced Genomics and Imaging established at JHU

The Mark Foundation for Cancer Research announced today the creation of The Mark Foundation Center for Advanced Genomics and Imaging at the Johns Hopkins University, which will receive initial funding of $5 million over 2 years.

27 Jan 2020

Researchers develop new isolated limb infusion method for melanoma treatment

Worldwide, the incidence rates of skin cancer, like other types of cancer, is increasing. People in Europe and the Nordic countries are, compared to other areas of the world, at a higher risk of developing skin cancer due to their predominantly light and sun-sensitive skin type. The number of new cases of cancer in Estonia and Nordic countries has reached the same level as in sunny Australia, New Zealand and Florida. The increasing trend among Estonians to travel to southern counties is also likely to play a role in this.

27 Jan 2020

First glioblastoma patient treated with genetically modified poliovirus at UH

University Hospitals Seidman Cancer Center treated its first patient in a new clinical trial to validate the groundbreaking effects of the poliovirus on glioblastoma, a deadly Grade IV cancer of the brain.

24 Jan 2020

Immune system cells facilitate the invasive capacity of glioblastoma

In a study published in Brain Communications, a new Open Access publication of the well-known journal Brain, the team led by Carlos Barcia, researcher at Institut de Neurociències of the Universitat Autònoma de Barcelona, analyzed the role of immune cells in the expansion of glioblastoma, the most aggressive brain tumor.

23 Jan 2020

BHF announces shortlist of four CVD research projects competing for £30 million award

The British Heart Foundation (BHF) today announced its shortlist of four research projects competing for a single £30 million award.

23 Jan 2020

GW expands clinical trial of neoadjuvant immunotherapy for high-risk cutaneous squamous cell carcinoma

The Cutaneous Oncology Program at the George Washington University (GW) Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous squamous cell carcinoma.

22 Jan 2020

Discovery of potent immune cell that can destroy multiple types of cancer

The immune system is the body’s defense against harmful pathogens that may enter the body. Immune cells, such as white blood cells and macrophages work hand in hand to fight off disease-causing microorganisms, including cancer.

21 Jan 2020

Patient-specific tumor organoids may one day be used to personalize cancer treatment

A patient-specific tumor organoid platform developed by Wake Forest Institute for Regenerative Medicine researchers and their cancer center colleagues could someday take the guessing game out of immunotherapy treatments.

21 Jan 2020

Discovery of new killer T-cell offers hope of a 'one-size-fits-all' cancer therapy

Researchers at Cardiff University have discovered a new type of killer T-cell that offers hope of a "one-size-fits-all" cancer therapy.

21 Jan 2020

Steer clear of allergy triggers when buying gifts for Valentine’s Day

Valentine's Day tends to bring out the urge to "spend big" on gifts that will sweep your loved one off their feet. But some gifts can cause allergy and asthma symptoms and should be avoided no matter how much you think they might convey your devotion.

21 Jan 2020

Immunotherapy News and Research

Latest Immunotherapy News and Research

Death receptor pathway drives resistance to CAR T cell therapy

New target protein linked to regulation, movement of tumor-associated macrophages

Nanoparticle Trojan horse approach to clearing atherosclerotic plaques

New therapeutic strategy to fight against advanced melanoma

Groundbreaking study to investigate why cancer returns in some people and not others

Avacta demonstrates initial proof-of-concept for TMAC drug conjugates in pre-clinical study

The Mark Foundation Center for Advanced Genomics and Imaging established at JHU

Researchers develop new isolated limb infusion method for melanoma treatment

First glioblastoma patient treated with genetically modified poliovirus at UH

Immune system cells facilitate the invasive capacity of glioblastoma

BHF announces shortlist of four CVD research projects competing for £30 million award

GW expands clinical trial of neoadjuvant immunotherapy for high-risk cutaneous squamous cell carcinoma

Discovery of potent immune cell that can destroy multiple types of cancer

Patient-specific tumor organoids may one day be used to personalize cancer treatment

Discovery of new killer T-cell offers hope of a 'one-size-fits-all' cancer therapy

Steer clear of allergy triggers when buying gifts for Valentine’s Day

New technique accurately predicts which melanomas are likely to recur and spread

New melanoma test may better predict recurrence and improve patient care

UCR receives $2.2 million grant to target critical oncogenes of B-cell lymphoma 2

Estrogen plays a role in expansion of liver metastases in non-sex-specific cancers

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Immunotherapy News and Research

Latest Immunotherapy News and Research

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in